medigraphic.com
ISSN 2007-6800 (Print)

2019, Number 2

<< Back Next >>

Rev Mex Traspl 2019; 8 (2)

Growth potential in liver procurement from cadaveric donor

Martínez-Ulloa J, Baas JP, Domínguez T, Gamboa RE, López JL

Language: Spanish
References: 18
Page: 61-66
PDF size: 208.05 Kb.


ABSTRACT

Introduction: Mexico harvests 30% of the livers from its cadaveric donors, well below the statistics of other countries. Material and methods: This is an eight year retrospective review evaluating the number of harvested livers in the state of Yucatan. Results: 86 multi organ procurement surgeries were performed: 47 viable livers, 36 harvested livers, 11 livers declined by every transplant group in Mexico (23%). Of the 36 harvested livers: 80% were sent to a public institution, 77% were sent within the Mexican Republic and only seven livers were transplanted in Yucatan. 83% of the livers were procured by a single local surgeon in Yucatan. Conclusions: There is a lack in the use of the resource of a vital organ of 23% with a potential for immediate growth if all existing viable livers are used. The above can be achieved by local procurement teams, as well as a reviewing the current criteria in the procedure for distribution and allocation of deceases donor livers.


REFERENCES

  1. https://www.gob.mx/cms/uploads/attachment/file/289636/Presentaci_n_anual_2017.pdf.

  2. Dominguez-Gil B et al. The critical pathway for deceased donation. Transpl Int. 2011; 24 (4): 373-378.

  3. Memoria de Actividad. ONT 2017.

  4. Transplant trends UNOS https://unos.org/data/transplant-trends/#transplants_by_donor_type+organ+Liver.

  5. Instituto Nacional Central Único Coordinador de Ablación e Implante. Reporte 2017. http://www.incucai.gov.ar/index.php/prensa/institucionales/618-la-donacion-y-el-trasplante-en-argentina-2017

  6. Matesanz R et al. Strategies to optimize deceased organ donation. Transplantation Reviews. 2007; 21: 177-188.

  7. Martínez-Ulloa J. Estado actual en material de donación y trasplantes en Yucatán. Liderazgo y experiencia médica, 2018. pp. 75-77.

  8. http://www.cenatra.salud.gob.mx/descargas/contenido/trasplante/Reporte_Anual_2010.pdf.

  9. Balam-Pereira G. El perfil de la mortalidad en el Estado de Yucatán, México. Rev Biomed. 2002; 13: 1-8.

  10. Mendoza-Sánchez F. Trasplante hepático en México. Rev Mex de Trasp. 2018; 7 (1): 25-30.

  11. Murray et al. Epidemiology of liver cirrhosis. J Clin Exp Hepatol. 2015; 5 (3): 272.

  12. Mokdad AA et al. Liver cirrhosis mortality in 187 countries between 1980 and 2010: a systematic analysis. BMC Medicine. 2014; 12: 159

  13. Quiroz M et al. Estimación de costos de la atención de pacientes con cirrosis hepática en el Instituto Mexicano del Seguro Social. Salud Publica Mex. 2010; 52 (6): 493-501.

  14. Rodríguez M et al. Etiología y complicaciones de la cirrosis hepática en el Hospital Juárez de México. Rev Hosp Jua Mex. 2008; 75 (4): 257-263

  15. Ley para la donación y trasplantes de órganos, tejidos y células en el estado de Yucatán. Ley publicada en el Suplemento al Diario Oficial del Estado de Yucatán, el martes 19 de abril de 2011. Gobierno del Estado. Poder Ejecutivo. Decreto Número 403.

  16. Dib-Kuri A et al. Trasplantes de órganos y tejidos en México. Rev Invest Clin. 2005; 57 (2): 163-169

  17. Genc R. The logistics management and coordination in procurement phase of organ transplantation. Tohoku J Exp Med. 2008; 216: 287-296.

  18. Querevalú-Murillo Walter et al. Iniciativa para aumentar la donación de órganos y tejidos en México. Rev Fac Med (Méx). 2012; 55 (1): 12-17.




2020     |     www.medigraphic.com